Structured evidence table for Myo-Inositol Pcos Meta-Analysis, generated from 1 reusable source document in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Myo-Inositol Pcos Meta-Analysis | In addition to reproductive complications, PCOS is associated with several metabolic and systemic consequences (,). | 3 | Aydin Cil Mevra (2026) | Two decades of nutrition research in polycystic ovary syndrome: emerging patterns and scientific output (2004–2024) |
| Myo-Inositol Pcos Meta-Analysis | At this point, PCOS is associated with an increased risk for developing reproductive, metabolic, cardiovascular, oncological, and psychological disturbances (). | 3 | Aydin Cil Mevra (2026) | Two decades of nutrition research in polycystic ovary syndrome: emerging patterns and scientific output (2004–2024) |
| Myo-Inositol Pcos Meta-Analysis | Meta-analyses have revealed that women with PCOS exhibit a greater prevalence of cardiometabolic risk factors that increase long-term healthcare costs, including metabolic syndrome, type 2 diabetes mellitus, dyslipidemia/hyperlipidemia, hypertension, and chronic low-grade inflammation (,). | 3 | Aydin Cil Mevra (2026) | Two decades of nutrition research in polycystic ovary syndrome: emerging patterns and scientific output (2004–2024) |
| Myo-Inositol Pcos Meta-Analysis | 1 2 3 2–4 5 6 Polycystic ovary syndrome (PCOS) is among the most prevalent endocrine disorders in women of reproductive age, affecting approximately one in five women. | 3 | Aydin Cil Mevra (2026) | Two decades of nutrition research in polycystic ovary syndrome: emerging patterns and scientific output (2004–2024) |
Source documents